ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Candel Therapeutics Inc

Candel Therapeutics Inc (CADL)

7.755
0.73
(10.39%)
Closed September 18 4:00PM
7.95
0.195
( 2.51% )
Pre Market: 7:11AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
7.95
Bid
7.96
Ask
8.13
Volume
1,127
0.00 Day's Range 0.00
0.66 52 Week Range 14.33
Market Cap
Previous Close
7.755
Open
-
Last Trade
30
@
7.96
Last Trade Time
07:12:48
Financial Volume
-
VWAP
-
Average Volume (3m)
302,643
Shares Outstanding
32,084,777
Dividend Yield
-
PE Ratio
-6.55
Earnings Per Share (EPS)
-1.18
Revenue
-
Net Profit
-37.94M

About Candel Therapeutics Inc

Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies. Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
-
Candel Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CADL. The last closing price for Candel Therapeutics was $7.76. Over the last year, Candel Therapeutics shares have traded in a share price range of $ 0.66 to $ 14.33.

Candel Therapeutics currently has 32,084,777 shares outstanding. The market capitalization of Candel Therapeutics is $248.82 million. Candel Therapeutics has a price to earnings ratio (PE ratio) of -6.55.

CADL Latest News

Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

NEEDHAM, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal...

Candel Therapeutics Reports Second Quarter 2024 Financial ResultsΒ and Recent Corporate Highlights

Announced positive survival data from the phase 2 randomized controlled clinical trial of CAN-2409 in borderline resectable pancreatic cancerPresented positive topline overall survival data from...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.3520.45454545456.67.966.53063167.2237133CS
42.7753.47490347495.187.965.182782496.56530592CS
122.2639.71880492095.697.964.93026436.19230255CS
266.55467.8571428571.414.331.398630214696.7884338CS
526.74557.0247933881.2114.330.6616764396.24756749CS
1560.324.193971166457.6314.330.665808726.1792279CS
260-0.05-0.625814.780.665623796.21754013CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TBIOTelesis Bio Inc
$ 3.98
(192.65%)
10.57M
ZEOZeo Energy Corporation
$ 3.14
(175.44%)
4.47M
XCURExicure Inc
$ 6.00
(162.01%)
4.01M
VEROVenus Concept Inc
$ 0.8566
(70.47%)
4.66M
GLMDGalmed Pharmaceuticals Ltd
$ 10.36
(50.14%)
2.66M
PGNYProgyny Inc
$ 18.50
(-24.30%)
107.15k
VVOSVivos Therapeutics Inc
$ 3.22
(-22.03%)
384.15k
SBCSBC Medical Group Holdings Incorporated
 6.02
(-21.41%)
27.37k
ATMCAlphaTime Acquisition Corporation
$ 9.00
(-19.64%)
10
HPAIHelport AI Ltd
$ 4.78
(-18.98%)
64
FRGTFreight Technologies Inc
$ 0.1581
(27.60%)
29.82M
MAXNMaxeon Solar Technologies Ltd
$ 0.0989
(8.80%)
15.83M
TBIOTelesis Bio Inc
$ 3.98
(192.65%)
10.57M
VMARVision Marine Technologies Inc
$ 0.6905
(14.51%)
5.63M
SQQQProShares UltraPro Short QQQ
$ 7.88
(-6.19%)
5.19M

CADL Discussion

View Posts
Monksdream Monksdream 2 weeks ago
CADL under $7
πŸ‘οΈ0
Monksdream Monksdream 2 weeks ago
CADL under $7
πŸ‘οΈ0
Monksdream Monksdream 1 month ago
CADL 10Q due AUGUST 19
πŸ‘οΈ0
Monksdream Monksdream 1 month ago
CADL 10Q due MONDAY AUGUST 12
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
CADL under $7
πŸ‘οΈ0
TechandBio TechandBio 2 months ago
Cancer Killing Platforms. Candel and IceCure. I only bought a 5000 shares of $CADL at .88 sold half at 9.00 riding 2500 shares.. I'm accumulating shares of IceCure Literally has a cure rate for early breast cancer patients with a success rate at 97% with 5 year independent follow up DATA . Even more impressive is the late stage breast cancer data just came out with a year follow up with 92.5% success rate treating tumors twice the size as the ones treated in the early breast cancer patients. Cryoblast is seeing amazing results in Lung, Liver and Kidney Cancer. approved in 15 countries including Brazil, China and many EU countries. Insurance companies are on board and patients are using the technology in the USA but have to pay out of pocket until FDA approval. The minimally invasive medical space is growing companies like $PLSE went from 50 million market to a Billion in the last two years Pulse Biosciences and IceCure $ICCM have very cutting edge technology with better quicker results than surgery with procedures being done with local anesthetic in a in a doctors office being able to go home with in a few hours pretty remarkable. IceCure will see tremendous growth and one of the Richest families in Asia the Lee family Victor Lee an a early invester in Tencent owns 52% of IceCure shares.
$CADL.
πŸ‘οΈ0
PonkenPlonken PonkenPlonken 3 months ago
Remember them buying up 450k shares a second after the readout was released on May23 all the way into high 16s.
sooner or later, the data will speak again and everyone will have to listen to whats being said.
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
CADL under $10
πŸ‘οΈ0
falcon21 falcon21 4 months ago
added at 7.50 today
πŸ‘οΈ0
falcon21 falcon21 4 months ago
only 1.5 mil short
πŸ‘οΈ0
glenn1919 glenn1919 4 months ago
CADL................................a/h...................$$$$$$$$$$$$$$$$$$$$$$$$$$$
πŸ‘οΈ0
Monksdream Monksdream 5 months ago
CADL under $10
Months
πŸ‘οΈ0
skidoo31 skidoo31 5 months ago
Short squeeze coming soon, mm have been borrowing my shares.
πŸ‘οΈ0
PonkenPlonken PonkenPlonken 5 months ago
agree. mcap should be 1bln $+++.
institutions are waiting on the bid- then do the lifting on liquidity event.

LOTS of retail antihero-themed traders are short. Weak line of defense.
πŸ‘οΈ0
Roadtojourney Roadtojourney 5 months ago
I cant believe this is still sitting at 5. The orphan designation for pancreatic itself is huge. Makes no sense. Imo
πŸ‘οΈ0
PonkenPlonken PonkenPlonken 5 months ago
$CADL GROUNDBREAKING data... never before.
see latest presentation regarding pending data in nsclc and CRC
Check Paul Peter Tak vita... Its a home run
πŸ‘οΈ0
skidoo31 skidoo31 5 months ago
Good job, she’s got legs. Maybe it will cool off in the morning for another possible dip then it’s chart making time. Shorts are staying away from this one as the potential for blue sky breakout is very good.
πŸ‘οΈ0
Namaste Charting Namaste Charting 5 months ago
$cadl. The next few hours should be engaging to say the least
πŸ‘οΈ0
Actualfactual Actualfactual 5 months ago
Looking for a push towards previous double top of 11.30’s and then a breakout through to blue skies
πŸ‘οΈ0
Namaste Charting Namaste Charting 5 months ago
Sure is! Added some $cadl $6.50's here

She's got that look!
πŸ‘οΈ0
skidoo31 skidoo31 5 months ago
https://ir.candeltx.com/news-releases/news-release-details/candel-therapeutics-receives-fda-orphan-drug-designation-can
πŸ‘οΈ0
skidoo31 skidoo31 5 months ago
Chart is building nicely ..
πŸ‘οΈ0
Awl416 Awl416 5 months ago
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
πŸ‘οΈ0
philaya philaya 5 months ago
Short interest 0.89%...
Bears smarter than some.
πŸ‘οΈ0
philaya philaya 5 months ago
Will buy...
Any time low good.
πŸ‘οΈ0
Roadtojourney Roadtojourney 5 months ago
Thats it just goes up news and then sell on news?? There is no holding here??
πŸ‘οΈ0
skidoo31 skidoo31 5 months ago
Could be a blue sky breakout if all these fundamentals line up. Big potential here.
πŸ‘οΈ0
skidoo31 skidoo31 5 months ago
New here, do you have a link please? Thank you
πŸ‘οΈ0
stoxjock stoxjock 5 months ago
I am Getting Ready for tomorrow's Blast-off Opening at $15+, as we could possibly see news at 8:30AM about a 'Private Placement' of maybe 5M Common shares 'Unit's @$15.00/share Plus each Warrant in the unit exercisable at $15/common share, upon dosing of the 1st Patient in the Phase 3 trial...with total 'Net proceeds' of around $140M giving Runway to EOY 2026!
πŸ‘οΈ0
stoxjock stoxjock 5 months ago
This stock was 'walked down' in PPS Friday afternoon. I am fully loaded. This is going to move up north of $30+ next two months. It has catalyst "READOUTs' coming up next two months and then into 4rth Q. Do not sell out for peanuts profits if you want to make massive gains, just HODL it till EOY 2024.Also, very possible it could be taken out anytime...GLTA!
πŸ‘οΈ0
philaya philaya 5 months ago
Fund easy...
With the positive meds.
πŸ‘οΈ0
Roadtojourney Roadtojourney 5 months ago
All that volume and only up 3% lol??
πŸ‘οΈ0
philaya philaya 5 months ago
fomo monday...
fun to watch.
πŸ‘οΈ0
philaya philaya 5 months ago
friday selling...
nothing matter.
πŸ‘οΈ0
Monksdream Monksdream 5 months ago
CADL new 52 hi
πŸ‘οΈ0
philaya philaya 5 months ago
buy the dip...
got some.
πŸ‘οΈ0
Awl416 Awl416 5 months ago
Hilarious
πŸ‘οΈ0
Awl416 Awl416 5 months ago
LOL
πŸ‘οΈ0
Invest-in-America Invest-in-America 5 months ago
CADL: See latest 'CHART', below!!!!
πŸ‘οΈ0
Awl416 Awl416 5 months ago
This action is entertaining
πŸ‘οΈ0
axelvento axelvento 5 months ago
ALERT- Cash Position: Cash and cash equivalents as of December 31, 2023 were $35.4 million, as compared to $70.1 million as of December 31, 2022. Based on current plans and assumptions, the Company expects that its existing cash and cash equivalents will be sufficient to fund its current operating plan into the fourth quarter of 2024
πŸ‘οΈ0
axelvento axelvento 5 months ago
Phase 2 topline data for CAN-2409 in low-to-intermediate-risk, localized, non-metastatic prostate cancer expected in Q4 2024
Phase 3 topline data for CAN-2409 in localized intermediate/high-risk prostate cancer expected in Q4 2024
πŸ‘οΈ0
trader59 trader59 5 months ago
The dump here when the computers doing the trading are turned off is going to be brutal.
πŸ‘οΈ0
TIMGZ TIMGZ 6 months ago
you are very good at taking risk, that is why u are so rich. what about if it dips at 4a.
did you catch it early?
πŸ‘οΈ0
2020trader 2020trader 6 months ago
expecting lower
πŸ‘οΈ0
Invest-in-America Invest-in-America 6 months ago
CADL: Easiest money of the week, that's for sure, Capt. Tim!!! (And I'm still holding it all.)
πŸ‘οΈ0
TIMGZ TIMGZ 6 months ago
nice try****so far almost 500%*****
πŸ‘οΈ0
da_stock_analyst da_stock_analyst 6 months ago
#CADL 🔥 insane run today! What about tomorrow? $cadl
πŸ‘οΈ0
Monksdream Monksdream 6 months ago
You mean like when I bought GDDY
πŸ‘οΈ0
dinogreeves dinogreeves 6 months ago
Very true Monk, if one doesn't have a plan, most likely will lose it all.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock